© 1996 Oxford University Press
research-article |
Tumor progression and oxidant-antioxidant status
Groupe d'Epidémologie Métabolique,INSERM-CRLC 34298 Montpellier Cedex 5, France
1Centre Régional de Lutte contre le Cancer 34298 Montpellier Cedex 5, France
2To whom correspondence should be addressed
Severity of prognosis factors in breast cancer cases was found to be associated with an increase in plasma vitamin E and a decrease in plasma malondialdehyde (peroxid-ability index). The first aim of this study was to determine whether this association is also present in other cancers. Measurements were taken before therapy on 129 patients with various carcinomas. Cholesterol was also investigated, as vitamin E is closely related to this analyte. Patients were classified by tumor size (T
38 5 cm and T> 5 cm) and by invasion status, assessed by the presence of nodes and/or metastasis. The vitamin E/total cholesterol concentration ratio was higher and the cholesterol and malondialdehyde concentrations were significantly lower in the plasma of patients with large tumors or in whom nodes and/or metastasis were present, whatever the site. The multivariate analysis performed to measure the association of these analyte concentrations with tumor progression showed that the presence of nodes and/or metastases was inversely associated with a low vitamin E/total cholesterol ratio (OR, 0.5; CI, 0.3–1.1) and, directly associated with low plasma concentrations of cholesterol and malondialdehyde (OR, 3.0; CI, 1.3–6.8 and OR, 2.8; CI, 1.2–6.7 respectively). The same types of associations were identified with large tumors, but were less strong. Together these findings supported an alteration of lipid parameters related to the oxidant-antioxidant status in cancer patients. This alteration appears to be associated with tumor growth and progression in patients with various cancer sites.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Suzuki, Y. Ito, K. Wakai, M. Kawado, S. Hashimoto, H. Toyoshima, M. Kojima, S. Tokudome, N. Hayakawa, Y. Watanabe, et al. Serum Oxidized Low-Density Lipoprotein Levels and Risk of Colorectal Cancer: A Case-Control Study Nested in the Japan Collaborative Cohort Study Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bakan, S. Taysi, M. F. Polat, S. Dalga, Z. Umudum, N. Bakan, and M. Gumus Nitric Oxide Levels and Lipid Peroxidation in Plasma of Patients with Gastric Cancer Jpn. J. Clin. Oncol., May 1, 2002; 32(5): 162 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.J. Hodges, T.C. Orton, A.J. Strain, and J.K. Chipman Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation Carcinogenesis, November 1, 2000; 21(11): 2041 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, H. Kohno, M. Murakami, S. Kagami, and K. El-Bayoumy Suppressing Effects of Dietary Supplementation of the Organoselenium 1,4-Phenylenebis(methylene)selenocyanate and the Citrus Antioxidant Auraptene on Lung Metastasis of Melanoma Cells in Mice Cancer Res., July 1, 2000; 60(14): 3713 - 3716. [Abstract] [Full Text]
|
|